JPRN-UMIN000020397招募中1 期
Phase I/II Study of Chemoradiotherapy with Paclitaxel for Elderly Stage IB-III Esophageal Cancer - Phase I/II Study of Chemoradiotherapy with Paclitaxel for Elderly Esophageal Cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2) Infectious disease with systemic therapy indicated. 3) Severe psychiatric disease. 4) Continuous systemic steroid therapy. 5) Poorly controlled diabetes mellitus. 6) Severe pulmonary fibrosis or emphysema. 7) Unstable angina pectoris, or history of myocardial infarction within three months. 8) Other conditions not suitable for this study.
研究者
相似试验
招募中
1 期
elderly PTX-RTEsophageal CancerJPRN-jRCTs031180283Hamamoto Yasuo74
已完成
1 期
A phase I study of chemoradiotherapy (cisplatin and vinorelbine) with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung canceron-small-cell lung cancerJPRN-UMIN000003769Osaka Lung Cancer Study Group12
已完成
2 期
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancerJPRN-UMIN000010428West Japan Oncology Group44
尚未招募
1 期
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
招募中
1 期
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24